Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).

Doshi, Gurjyot K; Bhanegaonkar, Abhijeet; Kearney, Mairead; Bharmal, Murtuza; Cislo, Paul; Kim, Ruth; Boyd, Marley; Aguilar, Kathleen M; Phatak, Hemant

Doshi, Gurjyot K; Bhanegaonkar, Abhijeet; Kearney, Mairead; Bharmal, Murtuza; Cislo, Paul; Kim, Ruth; Boyd, Marley; Aguilar, Kathleen M; Phatak, Hemant.

Afiliação

Doshi GK; Texas Oncology, Houston, TX, USA.
Bhanegaonkar A; EMD Serono Research & Development Institute, Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
Kearney M; Merck KGaA, Darmstadt, Germany.
Bharmal M; EMD Serono Research & Development Institute, Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
Cislo P; Pfizer Inc., New York, NY, USA.
Kim R; Pfizer Inc., New York, NY, USA.
Boyd M; Data, Evidence and Insights, McKesson Life Sciences, The US Oncology Network, The Woodlands, TX, USA.
Aguilar KM; Data, Evidence and Insights, McKesson Life Sciences, The US Oncology Network, The Woodlands, TX, USA.
Phatak H; EMD Serono Research & Development Institute, Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.